Nureca Limited (NURECA) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.022x

Based on the latest financial reports, Nureca Limited (NURECA) has a cash flow conversion efficiency ratio of 0.022x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs44.46 Million ≈ $480.82K USD) by net assets (Rs1.99 Billion ≈ $21.49 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see NURECA company net worth for the company's overall valuation and market capitalisation.

Nureca Limited - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how Nureca Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Nureca Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nureca Limited ranked by their cash flow conversion efficiency. Explore Nureca Limited (NURECA) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company Cash Flow Conversion Efficiency
Creative Realities Inc
NASDAQ:CREX
0.057x
NUREXONE BIOLOGIC INC.
F:J90
-0.426x
Maat Pharma SA
PA:MAAT
-1.853x
Home Capital Rentals SOCIMI S.A.
MC:YHCR
0.021x
TPC Consolidated Ltd
AU:TPC
0.228x
Inspirisys Solutions Limited
NSE:INSPIRISYS
0.188x
Piolink Inc
KQ:170790
0.042x
Sunnic Technology & Merchandise
TWO:3360
-0.120x

Annual Cash Flow Conversion Efficiency for Nureca Limited (2017–2025)

The table below shows the annual cash flow conversion efficiency of Nureca Limited from 2017 to 2025. View Nureca Limited (NURECA) stock price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-03-31 Rs1.94 Billion
≈ $21.01 Million
Rs-190.83 Million
≈ $-2.06 Million
-0.098x -599.40%
2024-03-31 Rs1.93 Billion
≈ $20.88 Million
Rs-27.12 Million
≈ $-293.29K
-0.014x -126.76%
2023-03-31 Rs1.95 Billion
≈ $21.08 Million
Rs102.27 Million
≈ $1.11 Million
0.052x +662.22%
2022-03-31 Rs2.03 Billion
≈ $21.98 Million
Rs13.99 Million
≈ $151.30K
0.007x -96.78%
2021-03-31 Rs1.63 Billion
≈ $17.64 Million
Rs348.67 Million
≈ $3.77 Million
0.214x +140.30%
2020-03-31 Rs149.34 Million
≈ $1.62 Million
Rs-79.23 Million
≈ $-856.84K
-0.531x -1581.51%
2019-03-31 Rs85.45 Million
≈ $924.11K
Rs3.06 Million
≈ $33.09K
0.036x -37.78%
2018-03-31 Rs17.20 Million
≈ $186.01K
Rs990.00K
≈ $10.71K
0.058x +106.30%
2017-03-31 Rs102.45K
≈ $1.11K
Rs-93.62K
≈ $-1.01K
-0.914x --

About Nureca Limited

NSE:NURECA India Medical Devices
Market Cap
$35.70 Million
Rs3.30 Billion INR
Market Cap Rank
#23270 Global
#1282 in India
Share Price
Rs345.95
Change (1 day)
+4.09%
52-Week Range
Rs206.75 - Rs346.30
All Time High
Rs2117.13
About

Nureca Limited provides home healthcare and wellness products in India. The company offers chronic disease products, such as nebulizers, blood pressure monitors, finger pulse oximeters, glucose meters, and thermometers, as well as connected products; orthopedic products, including massagers, pain management products, posture correctors, and rehabilitation products; and humidifiers and steamers, p… Read more